Inspire Veterinary cancels $150K debt in exchange for 3M common shares at $0.05 each

INSPIRE VETERINARY PARTNERS, INC.

Cancelled $150,000 of outstanding principal under June 2025 promissory note with Target Capital 1 LLC.
Issued 3,000,000 shares of Class A common stock at $0.05 per share for the debt cancellation.
Shares issued in reliance on Section 3(a)(9) of the Securities Act; exemption from registration.
Debt cancellation reduces outstanding liabilities; common shares outstanding increased by 3M.
Transaction executed December 18, 2025, with shares delivered within two business days.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

INSPIRE VETERINARY PARTNERS, INC. issued 3,000,000 shares of the Company's Class A common stock of common stock to Target Capital 1 LLC for cancellation of $150,000 of outstanding principal.

Security: common stock
Shares: 3,000,000 shares of the Company's Class A common stock
Purchaser: Target Capital 1 LLC
Consideration: cancellation of $150,000 of outstanding principal

Exact text from the filing

On December 18, 2025, Inspire Veterinary Partners, Inc. (the “Company”), entered into a Cancellation and Exchange Agreement, (the “Agreement”) between the Company and Target Capital 1 LLC ( “Target”). Pursuant to the Agreement, the Company and Target agreed to cancel $150,000 of the outstanding principal amount under that certain promissory note issued by the Company to Target on June 10, 2025, as amended (the “June Note”), in exchange for 3,000,000 shares of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”).

View on SEC.gov

Browse all equity issuances →

INSPIRE VETERINARY PARTNERS, INC. filing history →

Source: SEC EDGAR

accession 0001213900-25-126179

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.